Cytokines in viral hepatitis

被引:202
作者
Koziel, MJ [1 ]
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Infect Dis,Inst Med, Boston, MA 02215 USA
关键词
cytokines; hepatitis B; hepatitis C;
D O I
10.1055/s-2007-1007107
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cytokines play art important role in the defense against viral infections, both indirectly, through determination of the predominant pattern of host response, and directly through inhibition of viral replication. However in the context of an inflammatory response against a virus, cytokines may also lead to liver damage. The importance of this is best demonstrated in hepatitis B virus (HBV). In acute HBV infection, a vigorous polyclonal cellular immune response is critical; thus type 1 cytokine release is essential to initiating an effective immune response. The cytokines released by CD4(+) and CD8(+) cells also play an important role in downregulation of HBV replication, demonstrating that it is possible to control a viral infection without the death of infected cells. However; if there there is a defect in the acute response, HBV becomes chronic: in that case, the presence of an ongoing suboptimal inflammatory response can activate the process of hepatic fibrosis. In hepatitis C infection, the role of cellular immune responses and cytokines is less clear Hepatitis C may be resistant to inhibition by cytokines, so cytokines may have a more prominent role in liver damage than in controlling viral replication. Both hepatitis B and C may have specific mechanisms to inhibit cytokine production, highlighting the critical role of these molecules in recovery from infection.
引用
收藏
页码:157 / 169
页数:13
相关论文
共 148 条
[61]   Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease [J].
Kakumu, S ;
Okumura, A ;
Ishikawa, T ;
Yano, M ;
Enomoto, A ;
Nishimura, H ;
Yoshioka, K ;
Yoshikai, Y .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (03) :458-463
[62]   Neutralization of transforming growth factor beta 1 augments hepatitis C virus-specific cytotoxic T lymphocyte induction in vitro [J].
Kanto, T ;
Takehara, T ;
Katayama, K ;
Ito, A ;
Mochizuki, K ;
Kuzushita, N ;
Tatsumi, T ;
Sasaki, Y ;
Kasahara, A ;
Hayashi, N ;
Hori, M .
JOURNAL OF CLINICAL IMMUNOLOGY, 1997, 17 (06) :462-471
[63]   A single peripheral CD8(+) T cell can give rise to progeny expressing type 1 and/or type 2 cytokine genes and can retain its multipotentiality through many cell divisions [J].
Kelso, A ;
Groves, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :8070-8075
[64]   The alpha chemokine, interleukin 8, inhibits the antiviral action of interferon alpha [J].
Khabar, KSA ;
AlZoghaibi, F ;
AlAhdal, MN ;
Murayama, T ;
Dhalla, M ;
Mukaida, N ;
Taha, M ;
AlSedairy, ST ;
Siddiqui, Y ;
Kessie, G ;
Matsushima, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) :1077-1085
[65]   X-gene product of hepatitis B virus induces apoptosis in liver cells [J].
Kim, H ;
Lee, H ;
Yun, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :381-385
[66]   ADENOVIRUS VAI RNA ANTAGONIZES THE ANTIVIRAL ACTION OF INTERFERON BY PREVENTING ACTIVATION OF THE INTERFERON-INDUCED ELF-2-ALPHA KINASE [J].
KITAJEWSKI, J ;
SCHNEIDER, RJ ;
SAFER, B ;
MUNEMITSU, SM ;
SAMUEL, CE ;
THIMMAPPAYA, B ;
SHENK, T .
CELL, 1986, 45 (02) :195-200
[67]   Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection [J].
Koziel, MJ ;
Walker, BD .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1997, 19 (01) :69-83
[68]   HLA CLASS I-RESTRICTED CYTOTOXIC T-LYMPHOCYTES SPECIFIC FOR HEPATITIS-C VIRUS - IDENTIFICATION OF MULTIPLE EPITOPES AND CHARACTERIZATION OF PATTERNS OF CYTOKINE RELEASE [J].
KOZIEL, MJ ;
DUDLEY, D ;
AFDHAL, N ;
GRAKOUI, A ;
RICE, CM ;
CHOO, QL ;
HOUGHTON, M ;
WALKER, BD .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2311-2321
[69]   The role of immune responses in the pathogenesis of hepatitis C virus infection [J].
Koziel, MJ .
JOURNAL OF VIRAL HEPATITIS, 1997, 4 :31-41
[70]  
KOZIEL MJ, 1992, J IMMUNOL, V149, P3339